| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 01/29/2004 | WO2004009595A1 Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors |
| 01/29/2004 | WO2004009594A2 Xanthine derivatives having adenosine a1-receptor antagonist properties |
| 01/29/2004 | WO2004009091A1 Purine derivatives as liver x receptor agonists |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/28/2004 | EP1383767A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 01/28/2004 | EP1383766A1 Disubstituted 1,7-guanines |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | CN1471526A Dioxolane analogs for improved inter-cellular delivery |
| 01/22/2004 | WO2004007519A1 Partial and full agonists of a1 adenosine receptors |
| 01/22/2004 | WO2004007497A1 Process for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine |
| 01/22/2004 | WO2004006867A2 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents |
| 01/22/2004 | WO2003022805A3 Heterocycle substituted purines as antiproliferative agents |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014773 Purine and isosteric antibacterial compounds |
| 01/22/2004 | US20040014766 Antidiabetic agents |
| 01/22/2004 | US20040014748 Cardiovascular disorders, central nervous susyem disorders |
| 01/21/2004 | EP1382343A1 Combination therapy to treat hepatitis B virus |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/15/2004 | US20040009992 Azolylalkylazole derivatives, their preparation, and their use as pesticides |
| 01/15/2004 | US20040009544 Thermolabile caffeine fraction of tea leaves and an efficient method of introducing Agrobacterium-mediated genetic transformation in plants |
| 01/14/2004 | EP1380303A1 Combination therapy to treat hepatitis B virus |
| 01/14/2004 | EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 01/14/2004 | EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/13/2004 | US6677316 Adenosine derivatives and methods of administration |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/08/2004 | WO2004002990A2 Synthesis of purine derivatives |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002481A1 Aryl carbonyl derivatives as therapeutic agents |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006007 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
| 01/08/2004 | CA2744893A1 Aryl carbonyl derivatives as glucokinase activators |
| 01/08/2004 | CA2488562A1 Synthesis of purine derivatives |
| 01/07/2004 | EP1377579A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 01/07/2004 | CN1466587A Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/07/2004 | CN1133611C Substances capable of inducing appotosis |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/06/2004 | US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics |
| 01/02/2004 | EP1375502A1 Process for producing 2,6-dihalogenopurine |
| 01/02/2004 | EP1373247A2 Spiroisoquinoline compounds, methods for their preparation and intermediates thereof |
| 01/02/2004 | EP1373222A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/31/2003 | WO2004000843A1 NOVEL PURINE- OR PYRROLOL[2,3-d]PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY |
| 12/31/2003 | WO2004000320A1 Water-based preparation for eye drop |
| 12/31/2003 | WO2003066586A3 Purine and isosteric antibacterial compounds |
| 12/30/2003 | CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia |
| 12/25/2003 | WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 12/24/2003 | WO2003106459A1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 12/24/2003 | WO2003106458A1 Alkynylpurine compounds and production methods thereof |
| 12/24/2003 | WO2003105770A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/24/2003 | WO2003105666A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | CA2489468A1 Alkynylpurine compounds and production methods thereof |
| 12/24/2003 | CA2489179A1 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | CA2488842A1 Carbocyclic nucleoside analogs as rna-antivirals |
| 12/23/2003 | US6667311 Also containing pyrimidine or pyridine rings |
| 12/23/2003 | US6667300 Purinyl substituted quinazoline-4-one derivatives |
| 12/18/2003 | WO2003104440A2 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 12/18/2003 | WO2003104229A1 Novel fused imidazole derivative |
| 12/18/2003 | US20030232987 Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof |
| 12/18/2003 | US20030232845 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 12/17/2003 | EP1370568A1 Chemical compounds |
| 12/17/2003 | EP1370267A2 Use of propentofylline to control intraocular pressure |
| 12/17/2003 | CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003101992A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof |
| 12/11/2003 | WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 12/11/2003 | WO2003101442A1 Peptide deformylase inhibitors |
| 12/11/2003 | WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/11/2003 | WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 12/11/2003 | US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents |
| 12/11/2003 | US20030229106 Antihistamines, diarrhea |
| 12/11/2003 | US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 12/11/2003 | US20030228355 Precipitation of lipid; fineness particle size |
| 12/11/2003 | CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 12/11/2003 | CA2483923A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof |
| 12/10/2003 | EP1368350A1 Novel crystal forms of 9-substituted hypoxanthine derivatives |
| 12/10/2003 | EP1368349A1 Xanthine derivative, production and use thereof as a medicament |
| 12/10/2003 | EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 12/10/2003 | EP1058687B1 Nucleosides |
| 12/10/2003 | EP0915874B1 Process of preparation of valacyclovir and relevant intermediates |
| 12/10/2003 | CN1130363C Purine derivatives and medicine containing the same as active ingredient |
| 12/10/2003 | CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV) |
| 12/09/2003 | US6660745 Phosphodiesterase inhibitors; treatment of asthma, chronic obstructive pulmonary disease, inflammatory disorders |
| 12/09/2003 | US6660731 Pyrazole compounds useful as protein kinase inhibitors |
| 12/09/2003 | CA2069202C The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery |
| 12/04/2003 | WO2003099787A1 Novel piperidine compound |
| 12/04/2003 | WO2003099776A1 Calcium receptor modulating arylalkylamines |
| 12/04/2003 | WO2003099342A1 Labeled adenosine for use in positron emission tomography |